SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FatMatty who wrote (2831)	7/8/1998 7:46:00 PM
From: Gwolf	Read Replies (1) of 5402

Just a update on the total funding requirements. Dr. Drees reported that it will take $20 million to completely fund the trials. After further discussions I have found out that number is incorrect. The actual animal and human testing will require $8-$10 million in total. Dr Drees included another $10-$12 million to fully bring the product to market. That additional $8-$10 million would include raw material and manufacturing cost,marketing and administrative expenses.So the actual funding would be $8-$10 million, this would come from joint venturing with the major drug companies that he mentioned, through an additional underwriting of stock or a complete buyout of the company. Gwolf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next